当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts.
Blood ( IF 21.0 ) Pub Date : 2022-11-17 , DOI: 10.1182/blood.2022016171
Amer M Zeidan 1 , Uwe Platzbecker 2 , Guillermo Garcia-Manero 3 , Mikkael A Sekeres 4 , Pierre Fenaux 5 , Amy E DeZern 6 , Peter L Greenberg 7 , Michael R Savona 8 , Joseph G Jurcic 9 , Amit K Verma 10 , Ghulam J Mufti 11 , Rena Buckstein 12 , Valeria Santini 13 , Jeevan K Shetty 14 , Rodrigo Ito 15 , Jennie Zhang 15 , George Zhang 15 , Xianwei Ha 15 , Jay T Backstrom 16 , Rami S Komrokji 17
Affiliation  



中文翻译:

luspatercept 在输血依赖性低风险骨髓增生异常综合征(环状铁粒幼细胞)中的长期获益。

更新日期:2022-07-07
down
wechat
bug